SANOFI-AVENTIS (EPA:SAN) Press Release: Dupixent® (dupilumab) late-breaking data at AAD show significant improvements in signs and symptoms of moderate-to-severe atopic hand and foot dermatitis
Directive transparence : information réglementée
18/03/2023 15:00
27/10/2023 07:31
27/10/2023 07:31
22/10/2023 21:00
22/10/2023 21:00
18/10/2023 10:45
18/10/2023 10:45
17/10/2023 20:18
17/10/2023 20:18
13/10/2023 16:00
13/10/2023 16:00